MSI-H or dMMR Solid Tumors

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab1Terminated1
DB14765Rivoceranib1Terminated1